Geriatrik Hastalarda Hepatit B Virüs (Hbv) Enfeksiyonu
Anahtar Kelimeler
With the increase in the elderly population all over the
world, hepatitis B is becoming an important problem day by day. Especially the
weakening of the immune system that occurs with aging, inadequate vaccination,
low vaccine response rates compared to young people, physiological changes that
occur with aging and the presence of accompanying comorbidities increase the
burden of hepatitis B disease in the elderly. The risk of chronic liver disease
and hepatocellular carcinoma (HCC), the most feared complications of chronic
hepatitis B, increases with age. Therefore, elderly patients should be closely
monitored for these complications. although the specific indications for
treatment of chronic hepatitis B are clearly stated in current international
guidelines, the management of chronic hepatitis B in elderly patients is
complex. Physiologic changes and comorbidities that develop in old age
complicate treatment decisions in patients. When starting treatment for
patients, many factors such as patients’ physiological changes, accompanying
comorbidities, compliance with and toleration of treatment, burden of
treatment, and realistic treatment goals must be taken into account. The final
treatment decision should be made between the clinician and the patient, taking
into account the patient’s clinical condition. Vaccination is the best way to
prevent hepatitis B. Vaccination of elderly patients at high risk is extremely
important to reduce the morbidity and mortality caused by hepatitis B.
Bu kitabın bölümleri bulunmamaktadır.
Atıf Sayısı :
